RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis

Huiguang Xue, Aihua Yang, Fuguo Liu, Xueguo Sun, Xishuang Liu

Open source

DOI
10.1177/2058739218781291
Published
6
Container
European Journal of Inflammation
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/2058739218781291,
  title = {RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis},
  author = {Huiguang Xue and Aihua Yang and Fuguo Liu and Xueguo Sun and Xishuang Liu},
  year = {2018},
  journal = {European Journal of Inflammation},
  doi = {10.1177/2058739218781291},
  url = {https://doi.org/10.1177/2058739218781291}
}

RIS

TY  - JOUR
TI  - RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis
AU  - Huiguang Xue
AU  - Aihua Yang
AU  - Fuguo Liu
AU  - Xueguo Sun
AU  - Xishuang Liu
PY  - 2018
JO  - European Journal of Inflammation
DO  - 10.1177/2058739218781291
UR  - https://doi.org/10.1177/2058739218781291
ER  - 

APA

Xue, H., Yang, A., Liu, F., Sun, X., & Liu, X. (2018). RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis. European Journal of Inflammation. https://doi.org/10.1177/2058739218781291

Source records